BILL Holdings Valuation
Is BILL1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BILL1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BILL1 * (MX$994.02) is trading below our estimate of fair value (MX$1151.74)
Significantly Below Fair Value: BILL1 * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BILL1 *?
Other financial metrics that can be useful for relative valuation.
| What is BILL1 *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$5.95b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4.3x |
| Enterprise Value/EBITDA | -74.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BILL1 *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9.1x | ||
MARA Marathon Digital Holdings | 11.6x | 26.3% | US$5.8b |
HCP HashiCorp | 11.5x | 13.4% | US$6.7b |
SMAR Smartsheet | 6x | 14.4% | US$5.7b |
COUP Coupa Software | 7.5x | 16.0% | US$6.1b |
BILL1 * BILL Holdings | 4.7x | 13.1% | Mex$6.0b |
Price-To-Sales vs Peers: BILL1 * is good value based on its Price-To-Sales Ratio (4.7x) compared to the peer average (9.7x).
Price to Earnings Ratio vs Industry
How does BILL1 *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: BILL1 * is expensive based on its Price-To-Sales Ratio (4.7x) compared to the Global Software industry average (3x).
Price to Sales Ratio vs Fair Ratio
What is BILL1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 4.7x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BILL1 *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$994.02 | Mex$1,384.07 +39.2% | 16.8% | Mex$1,826.31 | Mex$996.17 | n/a | 22 |
| May ’25 | Mex$1,086.96 | Mex$1,443.63 +32.8% | 15.3% | Mex$1,871.96 | Mex$1,021.07 | n/a | 23 |
| Apr ’25 | n/a | Mex$1,448.39 0% | 14.5% | Mex$1,829.47 | Mex$997.89 | n/a | 23 |
| Mar ’25 | Mex$1,110.99 | Mex$1,493.83 +34.5% | 13.7% | Mex$1,879.36 | Mex$1,110.53 | n/a | 23 |
| Feb ’25 | n/a | Mex$1,467.30 0% | 15.5% | Mex$1,879.52 | Mex$1,042.28 | n/a | 24 |
| Jan ’25 | n/a | Mex$1,413.01 0% | 17.3% | Mex$1,868.75 | Mex$1,036.30 | n/a | 23 |
| Dec ’24 | n/a | Mex$1,484.81 0% | 20.9% | Mex$2,267.88 | Mex$1,058.46 | n/a | 24 |
| Nov ’24 | n/a | Mex$2,361.69 0% | 19.0% | Mex$3,605.96 | Mex$1,622.68 | n/a | 25 |
| Oct ’24 | n/a | Mex$2,266.38 0% | 19.5% | Mex$3,425.22 | Mex$1,541.35 | n/a | 23 |
| Sep ’24 | n/a | Mex$2,244.16 0% | 20.4% | Mex$3,418.26 | Mex$1,247.66 | n/a | 24 |
| Aug ’24 | n/a | Mex$2,197.98 0% | 20.9% | Mex$3,336.28 | Mex$1,151.02 | n/a | 24 |
| Jul ’24 | n/a | Mex$2,036.54 0% | 22.8% | Mex$3,422.40 | Mex$1,180.73 | n/a | 24 |
| Jun ’24 | n/a | Mex$2,065.89 0% | 22.8% | Mex$3,510.68 | Mex$1,211.18 | n/a | 25 |
| May ’24 | n/a | Mex$2,104.15 0% | 25.6% | Mex$3,595.98 | Mex$988.89 | Mex$1,086.96 | 25 |
| Apr ’24 | n/a | Mex$2,373.39 0% | 24.6% | Mex$3,723.90 | Mex$1,024.07 | n/a | 25 |
| Mar ’24 | n/a | Mex$2,536.37 0% | 18.3% | Mex$3,731.50 | Mex$1,772.46 | Mex$1,110.99 | 23 |
| Feb ’24 | n/a | Mex$3,073.85 0% | 22.8% | Mex$4,692.30 | Mex$1,970.77 | n/a | 24 |
| Jan ’24 | n/a | Mex$3,537.26 0% | 16.5% | Mex$4,853.43 | Mex$2,135.51 | n/a | 22 |
| Dec ’23 | n/a | Mex$3,537.26 0% | 16.5% | Mex$4,853.43 | Mex$2,135.51 | n/a | 22 |
| Nov ’23 | n/a | Mex$4,012.60 0% | 18.4% | Mex$5,982.87 | Mex$2,193.72 | n/a | 22 |
| Oct ’23 | n/a | Mex$4,302.07 0% | 15.7% | Mex$6,024.24 | Mex$2,871.55 | n/a | 21 |
| Sep ’23 | n/a | Mex$4,304.86 0% | 16.2% | Mex$6,000.90 | Mex$2,860.43 | n/a | 19 |
| Aug ’23 | n/a | Mex$3,757.11 0% | 25.2% | Mex$6,115.23 | Mex$2,548.01 | n/a | 19 |
| Jul ’23 | n/a | Mex$3,991.57 0% | 23.2% | Mex$6,009.06 | Mex$2,503.78 | n/a | 18 |
| Jun ’23 | n/a | Mex$3,980.06 0% | 22.0% | Mex$5,904.48 | Mex$2,460.20 | n/a | 18 |
| May ’23 | n/a | Mex$6,241.59 0% | 15.7% | Mex$7,764.43 | Mex$4,086.54 | n/a | 17 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.